Journal
CURRENT CANCER DRUG TARGETS
Volume 5, Issue 7, Pages 543-549Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156800905774574066
Keywords
copper depletion; angiogenesis; tetrathiomolybdate
Categories
Funding
- NCI NIH HHS [R01-CA77612] Funding Source: Medline
Ask authors/readers for more resources
Copper is a trace element which is tightly regulated in mammals and lower animals. Disruptions of copper homeostasis in humans are rare and they cause serious disorders such as Wilson's disease and Menke's disease. Copper plays an important role in promoting physiological and malignant angiogenesis. Formation of new blood vessels by a tumor enables tumor growth, invasion, and metastasis are copper requiring processes. The copper chelator tetrathiomolybdate (TM), which quickly and effectively depletes copper stores, is under investigation as an anti-angiogenic agent. Promising results from in vitro experiments, in pre-clinical animal models, and in a phase I clinical trial have led to several phase II trials of TM in patients with advanced cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available